Countable Labs
PrivateLast Round
Early Funding
May 28, 2026
Total Funding Raised
$27.91M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Countable Labs operates in Healthcare & Life Sciences and is based in Palo Alto, California. Its latest recorded funding round was an Early Funding round in May 2026.
Countable Labs is a healthcare technology company that develops a next-generation genomics platform for high-resolution, single-molecule DNA counting.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Countable Labs Comparables
Compare Countable Labs with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RainSure Scientific | 79% | |
| JN Medsys | 78% | |
| MillionMolecules | 73% |
For institutional investors. Book with your work email.
Countable Labs Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | May 28, 2026 | ||||
| Grant | Apr 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Countable Labs Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| Primer Ventures | VC Round, Early Funding |
| National Institute of General Medical Sciences | Grant |
| ARCH Venture Partners | VC Round, Early Funding |
| F-Prime Capital | VC Round, Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 28, 2026
$26M raised, led by ARCH Venture Partners.
- May 20, 2026
Monthly visitors grew 33% MoM, from 3.1K to 4.1K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- launchesSep 24, 2026
On Oct 2nd '26, Countable Labs, Inc. announced its entry into the clinical market with Ancora assays for oncology applications in California, offering absolute molecular quantification through Countable PCR technology.
For institutional investors. Book with your work email.
Countable Labs Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Countable Labs's valuation, stock price, and market status.
Is Countable Labs a public or private company?
Countable Labs is a private company.
What is the current stock price of Countable Labs?
Countable Labs is a private company, so its shares have no public market price. Caplight tracks Countable Labs's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Countable Labs worth (valuation)?
Valuation information for Countable Labs is not publicly available.
Can I buy Countable Labs stock?
Countable Labs shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Countable Labs's last funding round?
Countable Labs's most recent funding round was Early Funding on May 28, 2026.
Who are the main investors in Countable Labs?
Key investors in Countable Labs include National Institute of General Medical Sciences, ARCH Venture Partners.
Will Countable Labs IPO soon?
No public IPO plans have been announced for Countable Labs.
How can I track Countable Labs secondary market activity?
Caplight tracks bids, offers, and trades in Countable Labs's shares on secondary markets.